9825748

Source:http://linkedlifedata.com/resource/pubmed/id/9825748

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023981, umls-concept:C0024141, umls-concept:C0030705, umls-concept:C0085278, umls-concept:C0162596
pubmed:issue	10
pubmed:dateCreated	1998-12-3
pubmed:abstractText	To determine anti-beta2 glycoprotein-I (anti-beta2GPI) and anti-prothrombin (anti-ProT) antibody levels, and the IgG subclass distribution of anti-beta2GPI antibodies, in serial samples from patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) having initial or recurrent thrombotic/neurological (T/N) events during the study period. To investigate the correlations between these antibodies and beta2GPI antigen, anticardiolipin antibody (aCL), anti-double-stranded (ds) DNA, C3 levels and disease activity.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8302415
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Anticardiolipin, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Antinuclear, http://linkedlifedata.com/resource/pubmed/chemical/Complement C3, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M, http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin, http://linkedlifedata.com/resource/pubmed/chemical/beta 2-Glycoprotein I
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0263-7103
pubmed:author	pubmed-author:DonohoeSS, pubmed-author:InariKK, pubmed-author:IsenbergD ADA, pubmed-author:MachiiTT, pubmed-author:MackieII, pubmed-author:Radway-BrightE LEL, pubmed-author:RavirajanC TCT
pubmed:issnType	Print
pubmed:volume	37
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1089-94
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9825748-Adult, pubmed-meshheading:9825748-Antibodies, Anticardiolipin, pubmed-meshheading:9825748-Antibodies, Antinuclear, pubmed-meshheading:9825748-Antiphospholipid Syndrome, pubmed-meshheading:9825748-Cerebrovascular Disorders, pubmed-meshheading:9825748-Complement C3, pubmed-meshheading:9825748-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:9825748-Female, pubmed-meshheading:9825748-Glycoproteins, pubmed-meshheading:9825748-Humans, pubmed-meshheading:9825748-Immunoglobulin G, pubmed-meshheading:9825748-Immunoglobulin M, pubmed-meshheading:9825748-Longitudinal Studies, pubmed-meshheading:9825748-Lupus Erythematosus, Systemic, pubmed-meshheading:9825748-Middle Aged, pubmed-meshheading:9825748-Prothrombin, pubmed-meshheading:9825748-Thrombosis, pubmed-meshheading:9825748-beta 2-Glycoprotein I
pubmed:year	1998
pubmed:articleTitle	Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
pubmed:affiliation	Department of Medicine, University College London.
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't